These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19849765)

  • 1. Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: role of insulin resistance.
    Yilmaz Y; Alahdab YO; Ozdogan O; Dolar E
    Intern Med J; 2009 Oct; 39(10):709-10. PubMed ID: 19849765
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes.
    Hwang ST; Cho YK; Yun JW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Rhee EJ; Oh KW; Lee WY; Jin W
    Intern Med J; 2010 Jun; 40(6):437-42. PubMed ID: 19460054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients.
    Anan F; Masaki T; Iwao T; Eto T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
    Curr Med Res Opin; 2008 Jun; 24(6):1561-7. PubMed ID: 18423105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non-insulin-dependent diabetes (NIDDM).
    Chan JC; Tomlinson B; Nicholls MG; Swaminathan R; Cheung CK; Woo J; Cockram CS
    Diabet Med; 1996 Feb; 13(2):150-5. PubMed ID: 8641120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Sep; 22(9):1146-50. PubMed ID: 16108840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and endothelial dysfunction in type 2 diabetic patients with non-alcoholic steatohepatitis.
    Kawashima S; Suzuki M; Kaneto H; Imano E; Haruna Y; Nishimura Y; Kawashima A; Hatazaki M; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabet Med; 2009 Jun; 26(6):661-3. PubMed ID: 19538246
    [No Abstract]   [Full Text] [Related]  

  • 11. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
    Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
    Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
    Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis.
    Amarapurkar DN; Patel ND
    Trop Gastroenterol; 2004; 25(3):125-9. PubMed ID: 15682659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.